Results 101 to 110 of about 350,478 (232)

Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine [PDF]

open access: yes, 2013
Streptococcus pneumoniae causes invasive infections, primarily at the extremes of life. A seven-valent conjugate vaccine (PCV7) is used to protect against invasive pneumococcal disease in children.
Nicholas J Loman   +53 more
core   +1 more source

Epidemiological Assessment of the First Results of the National Program of Immunization of Young Children against Pneumococcal Infection in Russia

open access: yesЭпидемиология и вакцинопрофилактика, 2017
Pneumococcal infections are among the most common infections are an important cause of morbidity and mortality worldwide, including Russia. At the end of 2014 in the national immunization schedule countries introduced vaccination against pneumococcal ...
N. I. Brico   +16 more
doaj   +1 more source

Overwhelming Post‐Splenectomy Sepsis From Capnocytophaga canimorsus

open access: yes
International Journal of Laboratory Hematology, Volume 48, Issue 6, Page 1272-1273, December 2026.
Maitlyn Hsia   +3 more
wiley   +1 more source

Polysaccharide pneumococcal vaccination: new evidence.

open access: yes, 2006
Efficacy of anti‐pneumococcal vaccination in patients with ...
Hall, AJ
core   +1 more source

Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.

open access: yesPLoS ONE, 2019
BackgroundThe German Committee on Vaccination recommends pneumococcal vaccination for infants, seniors 60+ years and patients at risk with defined underlying diseases. Aim of this study was to assess the pneumococcal vaccination rate (pnc-VR) in patients
Niklas Schmedt   +5 more
doaj   +1 more source

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2603-2615, November 2026.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz   +17 more
wiley   +1 more source

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

open access: yes, 2010
In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance.
Perrocheau, Anne   +44 more
core   +1 more source

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

open access: yes, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
Zijlstra, EE   +26 more
core   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2370-2379, November 2026.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Coinfections With Respiratory Syncytial Virus in a Cohort of Adults With High‐Risk Conditions, 2015–2020: A Retrospective Observational Study

open access: yes
Health Science Reports, Volume 9, Issue 11, November 2026.
Oluwakemi D. Alonge   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy